02-28-2018 11:58 AM CET - Health & Medicine

Pulmonary Arterial Hypertension Market Key Players – Acceleron Pharma Inc, Biogen Inc, and Complexa Inc Global Analysis & Forecast 2017 to 2022

Press release from: WiseGuy Research consultants Pvt Ltd.
Pulmonary Arterial Hypertension


Pulmonary arterial hypertension (PAH) is a type of high blood pressure that occurs in the right side of the heart and in the arteries that supply blood to the lungs. Symptoms include chest pain, fatigue, passing out suddenly, and swelling of the legs (edema).

Risk factors include family history, age, obesity, obstructive sleep apnea and other diseases, including congenital heart disease, lung disease, liver disease and connective tissue disorders like scleroderma and lupus. Treatment includes sildenafil, prostanoids and calcium channel blockers.

Click here for sample report @ www.wiseguyreports.com/sample-request/2989071-pulmonary-a...

Top Companies mentioned

Acceleron Pharma Inc

Biogen Inc

Complexa Inc

Eli Lilly and Co

Galectin Therapeutics Inc

GlaxoSmithKline Plc

Insmed Inc

Insys Therapeutics Inc

Japan Tobacco Inc

Johnson & Johnson

Liquidia Technologies Inc

Pulmonary Arterial Hypertension Industry Major Outlook

Pharmaceutical and Healthcare latest pipeline guide Pulmonary Arterial Hypertension - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Pulmonary Arterial Hypertension, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Pulmonary Arterial Hypertension (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Pulmonary Arterial Hypertension and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, and Phase II, Phase I, Preclinical, Discovery and Unknown stages are 2, 9, 8, 21, 39, 2 and 1 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 5 and 1 molecules, respectively..

Pulmonary Arterial Hypertension - Competitive Analysis

Key players are making innovative developments in Pulmonary Arterial Hypertension industry.  The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector


The pipeline guide provides a snapshot of the global therapeutic landscape of Pulmonary Arterial Hypertension.

The pipeline guide reviews pipeline therapeutics for Pulmonary Arterial Hypertension by companies and universities/research institutes based on information derived from company and industry-specific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. 

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

The pipeline guide reviews key companies involved in Pulmonary Arterial Hypertension therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Pulmonary Arterial Hypertension therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects. 

The pipeline guide reviews latest news related to pipeline therapeutics for Pulmonary Arterial Hypertension.


For Detailed Reading Please visit @ www.wiseguyreports.com/reports/2989071-pulmonary-arterial...

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.
News-ID: 960864 • Views: 181
More releasesMore releases

You can edit or delete your press release here: